The appointment of a CEO from the biopharmaceutical industry suggests a strategic interest in healthcare and scientific innovation. This change in board composition could trigger reviews of R&D, technology platforms, and strategic partnerships to align with the new director's expertise.
Filing excerpt
On March 12, 2026, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate-Palmolive”) elected Christopher S. Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company (“Bristol Myers Squibb”), to the Colgate-Palmolive Board, effective March 15, 2026.
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
sec-8kgovernanceChangeGet every 8-K signal for Colgate-Palmolive and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Colgate-Palmolive this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/1c00e9cd-9bb5-43a8-985b-8a32e2cb5367 returns this record as JSON. POST /v1/companies/enrich returns every signal for colgatepalmolive.com.
{
"signal_id": "1c00e9cd-9bb5-43a8-985b-8a32e2cb5367",
"signal_type": "sec-8k",
"signal_subtype": "governanceChange",
"detected_at": "2026-03-17T07:30:27.369+00:00",
"company": {
"name": "Colgate-Palmolive",
"domain": "colgatepalmolive.com"
},
"data": {
"detail": "The appointment of a CEO from the biopharmaceutical industry suggests a strategic interest in healthcare and scientific innovation. This change in board composition could trigger reviews of R&D, technology platforms, and strategic partnerships to align with the new director's expertise.",
"metrics": {
"timeframe": "immediate"
},
"summary": "Colgate-Palmolive appoints Bristol-Myers Squibb CEO Christopher Boerner to its Board, effective March 15, 2026.",
"excerpts": "On March 12, 2026, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate-Palmolive”) elected Christopher S. Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company (“Bristol Myers Squibb”), to the Colgate-Palmolive Board, effective March 15, 2026.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/21665/000002166526000008/cl-20260312.htm",
"filing_date": "2026-03-12",
"filing_year": 2026,
"fiscal_year_end": "03/12",
"sales_relevance": "Governance tools needed",
"signal_category": "esg",
"vendors_mentioned": [
"McKinsey & Company"
]
}
}
curl https://signals.autobound.ai/v1/signals/1c00e9cd-9bb5-43a8-985b-8a32e2cb5367 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"colgatepalmolive.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.